Login to Your Account

Dutalys Gets First Taker for Bispecific Antibody Platform

By Cormac Sheridan
Staff Writer

Tuesday, December 18, 2012
Dutalys GmbH, an early stage company developing a bispecific antibody platform, entered a research collaboration with a top 10 pharmaceutical firm that could evolve into a product licensing alliance.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription